CVE:PBS Pacgen Life Science Co. (PBS.V) (PBS) Stock Price, News & Analysis → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free PBS Stock Alerts C$0.03 +0.01 (+20.00%) (As of 09/16/2020) Add Compare Share Share Today's RangeC$0.03▼C$0.0350-Day RangeC$0.03▼C$0.0352-Week RangeC$0.01▼C$0.05Volume2,000 shsAverage Volume63,601 shsMarket CapitalizationC$1.94 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pacgen Life Science Co. (PBS.V) alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Pacgen Life Science Co. (PBS.V)Pacgen Life Science Corporation, a life sciences company, focuses on building a commercial platform to market and distribute consumer health products in North America. It markets its oral and skin care products under the P113+, DermaMed, DermaSoleil, and Deserving Health brand names. The company was formerly known as Pacgen Biopharmaceuticals Corporation and changed its name to Pacgen Life Science Corporation in May 2012. Pacgen Life Science Corporation was founded in 2004 and is headquartered in Vancouver, Canada.Read More PBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBS Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive PBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pacgen Life Science Co. (PBS.V) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolCVE:PBS CUSIPN/A CIKN/A Webwww.pacgenlife.com Phone+1-604-4364388FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio78.48 Current Ratio0.81 Quick Ratio0.40 Sales & Book Value Annual SalesC$302,079.00 Price / Sales6.44 Cash FlowC$0.00 per share Price / Cash Flow30.00 Book ValueC$0.00 per share Price / Book-30.00Miscellaneous Outstanding Shares64,816,000Free FloatN/AMarket CapC$1.94 million OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesMr. Chung-Yu Wang B.Sc. (Age 74)Ph.D., EMBA, Co-Founder & Chairman Ms. Christina Yip MBA (Age 55)BBA (Honours), CPA, CMA, CEO, Pres & Director Mr. Fred Huang BA (Age 67)MBA, Co-Founder & Director Ms. Andrea ChanInterim CFO & Corp. Sec.Mr. Ivan WongExec. VP of OperationsKey CompetitorsMedifocus Inc. (MFS.V)CVE:MFSSolarvest BioEnergyCVE:SVSPascal BiosciencesCVE:PASiCo TherapeuticsCVE:ICOCotinga Pharmaceuticals Inc. (COT.V)CVE:COTView All Competitors PBS Stock Analysis - Frequently Asked Questions How have PBS shares performed in 2024? Pacgen Life Science Co. (PBS.V)'s stock was trading at C$0.03 at the beginning of the year. Since then, PBS shares have increased by 0.0% and is now trading at C$0.03. View the best growth stocks for 2024 here. Is Pacgen Life Science Co. (PBS.V) a good dividend stock? Pacgen Life Science Co. (PBS.V) (CVE:PBS) pays an annual dividend of C$0.09 per share and currently has a dividend yield of 0.00%. How do I buy shares of Pacgen Life Science Co. (PBS.V)? Shares of PBS stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:PBS) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThey say it’s ‘unstoppable’ – How I made 43,509% Investing Daily Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacgen Life Science Co. (PBS.V) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.